Who owns Elicio Therapeutics Inc Com?
- Ticker: ELTX
- CUSIP Number: 28657f103
Tip: Access positions for across all investors
Analyze quarterly positions in Elicio Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Elicio Therapeutics stock
Who bought or sold Elicio Therapeutics Inc Com this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Vanguard Group | 175k | $1.5M | 24% | Dec 2023 |
|
CM Management | 50k | $417k | -23% | Dec 2023 |
|
Citadel Advisors | 14k | $117k | -14% | Dec 2023 |
|
Meyer Handelman | 14k | $106k | 0% | Mar 2024 |
|
Steward Partners Investment Advisory | 1.6k | $13k | 0% | Dec 2023 |
|
Bank of America Corporation | 1.1k | $9.6k | -32% | Dec 2023 |
|
Citigroup | 374.00 | $3.1k | 0% | Dec 2023 |
|
Northwest Capital Management | 350.00 | $2.7k | 0% | Mar 2024 |
|
Royal Bank of Canada | 78.00 | $999.999000 | 37% | Dec 2023 |
|
Wells Fargo & Company | 43.00 | $358.998400 | 95% | Dec 2023 |
|
UBS Group | 16.00 | $133.000000 | 0% | Dec 2023 |
|
Who sold out of Elicio Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Nantahala Capital Management | Sep 2023 | 30k | $254k |
Millennium Management | Sep 2023 | 20k | $172k |
CWM | Dec 2023 | 100.00 | $1.0k |